Drastic changes in lifestyle aimed at improving dietary habits and regular physical activity, in some cases supplemented with drugs such as insulin sensitizers and lipid-lowering drugs [169], are currently the only therapeutic options to treat NAFLD/NASH [9]. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.